These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 28599426)
1. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma. Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304 [TBL] [Abstract][Full Text] [Related]
3. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-381 is associated with poor prognosis in papillary thyroid carcinoma. Huang T; Yi D; Xu L; Bu E; Zhu C; Sang J; Zhang Y Int J Clin Exp Pathol; 2017; 10(12):11610-11616. PubMed ID: 31966518 [TBL] [Abstract][Full Text] [Related]
5. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features. Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472 [TBL] [Abstract][Full Text] [Related]
6. Differential expression levels of plasma-derived miR-146b and miR-155 in papillary thyroid cancer. Lee YS; Lim YS; Lee JC; Wang SG; Park HY; Kim SY; Lee BJ Oral Oncol; 2015 Jan; 51(1):77-83. PubMed ID: 25456009 [TBL] [Abstract][Full Text] [Related]
7. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas. Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448 [TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. Yu S; Liu Y; Wang J; Guo Z; Zhang Q; Yu F; Zhang Y; Huang K; Li Y; Song E; Zheng XL; Xiao H J Clin Endocrinol Metab; 2012 Jun; 97(6):2084-92. PubMed ID: 22472564 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer. Chou CK; Liu RT; Kang HY Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980 [TBL] [Abstract][Full Text] [Related]
10. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas. Jiang K; Li G; Chen W; Song L; Wei T; Li Z; Gong R; Lei J; Shi H; Zhu J Onco Targets Ther; 2020; 13():1311-1319. PubMed ID: 32103998 [TBL] [Abstract][Full Text] [Related]
11. Circulating miR-25-3p and miR-451a May Be Potential Biomarkers for the Diagnosis of Papillary Thyroid Carcinoma. Li M; Song Q; Li H; Lou Y; Wang L PLoS One; 2015; 10(7):e0132403. PubMed ID: 26168287 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400 [TBL] [Abstract][Full Text] [Related]
13. Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma. Wang Z; Zhang H; He L; Dong W; Li J; Shan Z; Teng W Onco Targets Ther; 2013; 6():281-7. PubMed ID: 23569392 [TBL] [Abstract][Full Text] [Related]
14. Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma. Wen Q; Wang Y; Li X; Jin X; Wang G J Clin Lab Anal; 2021 Jan; 35(1):e23560. PubMed ID: 33368640 [TBL] [Abstract][Full Text] [Related]
15. Altered Serum MicroRNA Profile May Serve as an Auxiliary Tool for Discriminating Aggressive Thyroid Carcinoma from Nonaggressive Thyroid Cancer and Benign Thyroid Nodules. Zhang A; Wang C; Lu H; Chen X; Ba Y; Zhang C; Zhang CY Dis Markers; 2019; 2019():3717683. PubMed ID: 31636734 [TBL] [Abstract][Full Text] [Related]
16. Identification of Thyroid-Associated Serum microRNA Profiles and Their Potential Use in Thyroid Cancer Follow-Up. Rosignolo F; Sponziello M; Giacomelli L; Russo D; Pecce V; Biffoni M; Bellantone R; Lombardi CP; Lamartina L; Grani G; Durante C; Filetti S; Verrienti A J Endocr Soc; 2017 Jan; 1(1):3-13. PubMed ID: 29264441 [TBL] [Abstract][Full Text] [Related]
17. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Dai D; Tan Y; Guo L; Tang A; Zhao Y Eur J Endocrinol; 2020 Jan; 182(1):111-121. PubMed ID: 31721725 [TBL] [Abstract][Full Text] [Related]
18. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma. Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940 [TBL] [Abstract][Full Text] [Related]
19. Circulating microRNA124-3p, microRNA9-3p and microRNA196b-5p may be potential signatures for differential diagnosis of thyroid nodules. Yu S; Liu X; Zhang Y; Li J; Chen S; Zheng H; Reng R; Zhang C; Chen J; Chen L Oncotarget; 2016 Dec; 7(51):84165-84177. PubMed ID: 27705935 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma. Zhang M; Wu W; Gao M; Fei Z Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]